NH2
O
O
O
O
NH
NH
OMe
OMe
O
O
i
ii
O
O
N
4
N
NH2
5
5
6
5
iii
MeO
MeO
O
O
MeO
N
MeO
O
O
O
OMe
NH
N
N
MeO
O
O
N
HN
OMe
O
HN
O
O
O
N
OMe
MeO
MeO
MeO
NH
O
O
O
O
N
OMe
N
O
O
O
O
O
O
NH
NH
O
N
N
H
N
O
N
N
N
HN
O
O
O
O
O
O
N
O
OMe
O
N
NH
HN
MeO
O
OMe
O
N
O
MeO
OMe
MeO
O
O
OMe
MeO
7
Scheme 2 Reagents and conditions: i, methyl acrylate (22 equivs.), MeOH, 3 d, room temp., quant.; ii, ethylendiamine (600 equivs.), MeOH, 5 d, +5 °C,
quant. iii, methyl acrylate (60 equivs.), MeOH, 3 d, room temp., quant.
1 F. Zeng and S. C. Zimmerman, Chem. Rev., 1997, 97, 1681.
2 M. T. Reetz, G. Lohmer and R. Schwickardi, Angew. Chem., 1997, 109,
1559; Angew. Chem., Int. Ed. Engl., 1997, 36, 1526.
3 J. F. G. A. Jansen, E. M. M. de Brabander-van den Berg and E. W.
Meijer, Recl. Trav. Chim. Pays-Bas, 1995, 114, 225.
4 M. X. Tang, C. T. Redemann and F. C. Szoka, Bioconjugate Chem.,
1996, 7, 703.
properties compared to classical PAMAMs, such as altered
solubilities and overall shapes, better biodegradibility, lower
toxicity and chirality.
The authors wish to thank Dr V. Sinnwell for NMR
experiments, Professor Dr J. Thiem for his assistance and the
Fonds der Chemischen Industrie (FCI) for financial support.
5 D. Zanini and R. R. Roy, J. Am. Chem. Soc., 1997, 119, 2088.
Notes and References
6 N. Jayaraman, S. A. Nepogodiev and J. F. Stoddart, Chem. Eur. J., 1997,
3, 1193.
7 H. W. I. Peerlings and E. W. Meijer, Chem. Eur. J., 1997, 3, 1563; P. K.
Murer, J.-M. Lapierre, G. Greiveldinger and D. Seebach, Helv. Chim.
Acta, 1997, 80, 1648.
8 R. Esfand, A. E. Beezer, J. C. Mitchell and L. J. Twyman, Pharm. Sci.,
1996, 2, 1; D. M. Watkins, Y. Sayed-Sweet, J. W. Klimash, N. J. Turro
and D. A. Tomalia, Langmuir, 1997, 13, 3136.
9 R. M. Nouguier and M. Mchich, J. Org. Chem., 1985, 50, 3296.
10 S. L. Schreiber, R. E. Claus and J. Reagan, Tetrahedron Lett., 1982, 23,
3867.
† E-mail: tklind@chemie.uni-hamburg.de
‡ All compounds showed consistent NMR and mass spectral data. Selected
data for 7: MALDI-TOF (positive) [Calc. for C146H257N25O56: 3258.8.
Found 3261.0 (M + 1)]; dH(500 MHz, CD3OD) 5.02 (d, 1 H, J1,2 3.2, H-1),
4.03–3.93 (m, 2 H, OCH2CH2N), 3.88–3.59 (m, 73 H, H-5, H-6, H-6A, 4
OCH2CH2N, 20 OCH3), 3.54 (dd ≈ t, 1 H, J2,3 9.2, J3,4 9.2, H-3), 3.34–3.27
[m, 21 H, H-2, 10 C(O)NCH2CH2N], 3.26 (dd ≈ t, 1 H, J4,5 9.2, H-4),
3.0–2.89 [m, 20 H, 10 NCH2CH2C(O)N], 2.89–2.76 (dd ≈ t, 50 H, 5
OCH2CH2N, 20 NCH2CH2CO2Me), 2.64–2.57 [dd
C(O)NCH2CH2N], 2.54–2.49 (dd t, 40 H, 20 NCH2CH2CO2Me),
≈ t, 20 H, 10
≈
11 A. F. Abdel-Magid, K. G. Carson, B. D. Harris, C. A. Maryanoff and
R. D. Shah, J. Org. Chem., 1996, 61, 3849.
2.49–2.41 [dd ≈ t, 20 H, 10 NCH2CH2C(O)N]; dC 175.9 (20 CO2Me),
175.7–175.5 (10 CO2N), 99.2 (C-1), 84.5 (C-3), 83.2 (C-2), 80.9 (C-4), 73.1
(C-5), 73.0, 72.9, 72.5, 71.8, 70.7, 68.3 (C-6, 5 OCH2CH2N), 55.7, 55.6,
55.5, 55.0, 54.7 (5 OCH2CH2N), 55.0 [20 C(O)NCH2CH2N], 53.4 (20
CO2CH3), 52.7, 52.6, 52.6, 52.5, 52.5 [10 NCH2CH2C(O)N], 51.7 (20
NCH2CH2CO2Me), 39.7 [10 C(O)NCH2CH2N], 35.8, 35.7, 35.6, 35.6, 35.5
[10 NCH2CH2C(O)N], 34.8 (20 NCH2CH2 CO2Me).
12 S. Ram and L. D. Spicer, Tetrahedron Lett., 1987, 28, 515.
13 C. Kieburg, M. Dubber and T. K. Lindhorst, Synlett, 1997, 1447.
14 A. D. Miltzer, D. A. Tirrell, A. A. Jones, P. T. Inglefield, D. M.
Hedstrand and D. A. Tomalia, Macromolecules, 1992, 25, 4541.
15 D. Seebach, J.-M. Lapierre, G. Greiveldinger and K. Skobridis, Helv.
Chim. Acta, 1994, 77, 1673.
§ Selected specific optical rotations: 1 [a]2D0 +160.5 (c 1.09, MeOH); 3 [a]2D7
+35.2 (c 1.18, CHCl3); 5 [a]D27 +34.6 (c 0.96, MeOH); 7 [a]2D5 +13.1 (c 0.38,
MeOH).
Received in Liverpool, UK, 20th January 1998; 8/00560E
1266
Chem. Commun., 1998